Initial Clinical Trials: Acupuncture Treatment of Macular Degeneration
Gail Brent, L.Ac., San Diego, CA;
Heidi Day, L.Ac., Edmonds, WA;
Andrew Rosenfarb, MTOM, Dipl. Ac., Dipl. C.H., Westfield, NJ;
Mats Sexton L. Ac., St. Louis Park, MN.
August, 2004
Eighty-six patients diagnosed with Macular Degeneration were treated with Micro Acupuncture™ - a procedure involving 48 newly discovered acupuncture points located in the hands and feet, and not associated with any other acupuncture system. Five to six Micro Acupuncture™ treatments were administered, followed by a re-examination using the Perimetry Octopuss 1-2-3 visual field scanner, as well as a standard visual acuity test. Of the eighty-six patients treated, seventy-nine (almost 92%) had shown significant improvement - while seven had very little or no improvement - indicating that Micro Acupuncture™ is significantly effective in the treatment of Macular Degeneration.
The clinical objective in treating ARMD is to treat the root cause of the disease pattern. The branch treatment or temporary solution can be to activate the blood circulation in order to resolve stagnation. Visual capacity may be improved by promoting the circulation in choroids and retina, preventing cell death, and reversing the inability to absorb and circulate vital nutrients for healthy vision.
Acupuncture Treatment:
Body Points:
Distal: Li-3, Si-3, Ht-8, SJ-3, Sp-3, Ki-1, Sp-6, St-36
Local: UB-2 (same effect as UB-1), Yuyao, GB-14, Yintang
Ear Points: Adrenal, Pt. Zero, & Corpus Callosum
Note: These were initial clinical trials with more conclusive evidence to be proven in the form of double-blind research. Additional data - determining the efficacy of Micro Acupuncture™ - is currently being processed and researched for the treatment of Glaucoma, Retinitis Pigmentosa, Stargardt's Syndrome, and Diabetic Retinopathy.
Brent, Day, Rosenfarb & Sexton are all licensed by the NCCAOM. Each practitioner had received extensive training in the theories and clinical applications of Micro Acupuncture™, a system that has treated more than 5,000 people throughout Europe, and over 10,000 people in the United States.
|